What Does it Mean to be in the NSMP Category of Uterine Cancer?
Stephanie Gaillard, MD PHD, Director, Gynecologic Cancer Trials and Co-Director, Developmental Therapeutics/Phase I Clinical Trials Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. Dr. Gaillard will explain what the No Specific Molecular Profile (NSMP) category of endometrial/uterine cancer is and tell us about the research that is going on in the various subcategories of NSMP. […]
ASCO 2025: What’s New for MBC?
Get the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Our expert, Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, will break down key research and what it means for people living with MBC. Stay informed, ask questions, and join the conversation.
BRIA-ABC
Listen to Dr. Kelly McCann to learn about the BRIA-ABC clinical trial, a Phase 3 study evaluating a novel immunotherapy approach for patients with advanced metastatic or locally recurrent breast cancer. This multicenter, randomized, open-label trial compares three groups: one receiving Bria-IMT—a whole-cell cancer vaccine—combined with retifanlimab, an immune checkpoint inhibitor; a second group receiving […]
Living with Metastatic Lobular Breast Cancer (mILC): Challenges, Treatment, and New Developments
Join us for an informative webinar focused on metastatic lobular breast cancer (mILC). In this session, Dr. Sherry Shen, a breast medical oncologist at MSK, will provide insights into the unique challenges of mILC, explain how it differs from other types of breast cancer, and discuss the latest advancements in treatment. This is a great […]
Report Back from SGO: What’s New in Cervical Cancer?
Join us for a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Claire Hoppenot, a gynecologic oncologist at Baylor College of Medicine, will break down the research presented at the conference, discuss new developments, and address your questions. Key Takeaways: Our standard of care for sentinel lymph nodes […]
How Unlocking the Nucleus in TNBC Biomarkers Could Change the Game for Black Breast Cancer Patients
Triple-negative breast cancer (TNBC) presents unique challenges, especially for Black women, who are disproportionately affected by this aggressive form of breast cancer. In this webinar, we will dive into the science behind TNBC biomarkers in the cell’s nucleus and explore how these discoveries could revolutionize the future of treatment and survival outcomes. Our guest, Diva […]
What’s New in Uterine Cancer? Updates from the SGO Annual Meeting and Clinical Trial Opportunities
Join Dr. Joshua Cohen, Medical Director of the Gynecologic Cancer Program at City of Hope Orange County, as he provides an update from the 2025 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer and new emerging strategies/clinical trials for patients impacted by endometrial cancer. Dr. Cohen will break down the research presented at […]
Report Back from SGO: What’s New in Ovarian Cancer Research?
Are you curious about what’s new in ovarian cancer research? We invite you to join Dr. Premal Thaker, Distinguished Professor and interim Chief of Gynecologic Oncology at Siteman Cancer Center, to hear the latest updates from the Society of Gynecologic Oncology (SGO) Annual Meeting. Dr. Thaker will highlight what the research presented at the conference […]
Breaking Barriers: Breast Cancer Survival Rates in the Black Community & the Need for Black Scientists in Research
Join us for an insightful conversation on the disparities in breast cancer survival rates within the Black community and the urgent need for greater representation of Black scientists in the research field. Our guest, Diva Melvin, PhD, Assistant Professor, Pre Health Advisor in the Biology Department at Tougaloo College, will highlight how systemic inequities in […]